Clinical trial
Efficacy and Safety of Zolpidem-MR Administered Over a Long Term Period as…
NCT00425243 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00425243 |
|---|---|
| Title | Efficacy and Safety of Zolpidem-MR Administered Over a Long Term Period as Needed for Insomnia (ZOLONG) |
| Official title | Evaluation of the Long-Term Efficacy and Safety of Zolpidem-MR 12.5 mg Compared to Placebo, When Both Are Administered Over a Long-Term Period "as Needed", in Patients With Chronic Primary Insomnia |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sleep Initiation and Maintenance Disorders |
| Intervention type | Drug |
| Interventions | zolpidem-MR (SL800750) |
| Enrollment | 1,025 |
| Start date | Aug 1, 2004 |
| Primary completion | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | Jan 22, 2007 |
| Last update posted | Apr 6, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: